{"id":138781,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/ensayo-strategist3\/"},"modified":"2026-04-24T18:47:24","modified_gmt":"2026-04-24T18:47:24","slug":"ensayo-strategist3","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/es\/","title":{"rendered":"Ensayo StrateGIST3"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=\u00bb100&#8243; back_color=\u00bbcolor-138503&#8243; back_image=\u00bb141532&#8243; back_repeat=\u00bbno-repeat\u00bb back_attachment=\u00bbscroll\u00bb back_position=\u00bbcenter center\u00bb parallax=\u00bbyes\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider_inv=\u00bbtilt\u00bb shape_bottom_invert=\u00bbyes\u00bb shape_bottom_flip=\u00bbyes\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb100&#8243; shape_bottom_color=\u00bbcolor-773321&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb el_class=\u00bbgradient\u00bb uncode_shortcode_id=\u00bb175237&#8243; back_color_type=\u00bbuncode-palette\u00bb shape_bottom_color_type=\u00bbuncode-palette\u00bb row_name=\u00bbiphone\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb position_vertical=\u00bbbottom\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; expand_height=\u00bbyes\u00bb style=\u00bbdark\u00bb overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb7&#8243; align_mobile=\u00bbalign_center_mobile\u00bb mobile_width=\u00bb0&#8243; css_animation=\u00bbbottom-t-top\u00bb animation_delay=\u00bb200&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb177675&#8243; column_width_pixel=\u00bb1000&#8243;][vc_empty_space empty_h=\u00bb5&#8243;][vc_single_image media=\u00bb141530&#8243; media_width_percent=\u00bb36&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb371455&#8243;][vc_column_text text_color=\u00bbcolor-jevc\u00bb uncode_shortcode_id=\u00bb137548&#8243; text_color_type=\u00bbuncode-palette\u00bb]El IDRX-42 (GSK6042981) es un inhibidor altamente selectivo y potente de la prote\u00edna KIT, que es hiperactiva en muchas personas con GIST, lo que provoca el crecimiento y la acumulaci\u00f3n de las c\u00e9lulas cancerosas.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb100&#8243; back_color=\u00bbcolor-138503&#8243; back_image=\u00bb112267&#8243; back_repeat=\u00bbno-repeat\u00bb back_attachment=\u00bbfixed\u00bb back_position=\u00bbcenter top\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider_inv=\u00bbtilt\u00bb shape_bottom_invert=\u00bbyes\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb100&#8243; shape_bottom_color=\u00bbcolor-681992&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb row_name=\u00bbiphone\u00bb el_class=\u00bbgradient\u00bb uncode_shortcode_id=\u00bb159258&#8243; back_color_type=\u00bbuncode-palette\u00bb shape_bottom_color_type=\u00bbuncode-palette\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; style=\u00bbdark\u00bb overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb7&#8243; align_mobile=\u00bbalign_center_mobile\u00bb mobile_width=\u00bb0&#8243; css_animation=\u00bbbottom-t-top\u00bb animation_delay=\u00bb200&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb276875&#8243; column_width_pixel=\u00bb1000&#8243;][vc_empty_space empty_h=\u00bb1&#8243;][vc_single_image media=\u00bb138431&#8243; media_width_percent=\u00bb45&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb927066&#8243;][vc_empty_space empty_h=\u00bb1&#8243;][vc_button button_color=\u00bbcolor-681992&#8243; border_width=\u00bb0&#8243; uncode_shortcode_id=\u00bb158705&#8243; width=\u00bb216&#8243; link=\u00bburl:%23descripci%C3%B3ndelestudio|title:Preguntas%20frecuentes|\u00bb button_color_type=\u00bbuncode-palette\u00bb el_class=\u00bbnone-display\u00bb]M\u00e1s informaci\u00f3n[\/vc_button][vc_empty_space empty_h=\u00bb2&#8243;][vc_column_text text_color=\u00bbcolor-jevc\u00bb uncode_shortcode_id=\u00bb137548&#8243; text_color_type=\u00bbuncode-palette\u00bb]El IDRX-42 (GSK6042981) es un inhibidor altamente selectivo y potente de la prote\u00edna KIT, que es hiperactiva en muchas personas con GIST, lo que provoca el crecimiento y la acumulaci\u00f3n de las c\u00e9lulas cancerosas.[\/vc_column_text][vc_column_text text_color=\u00bbcolor-196438&#8243; uncode_shortcode_id=\u00bb854909&#8243; text_color_type=\u00bbuncode-palette\u00bb el_class=\u00bbnone-display\u00bb]Haga clic aqu\u00ed para ver un v\u00eddeo sobre StrateGIST 3, donde se explica el objetivo del estudio, qui\u00e9n puede participar, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_single_image media=\u00bb123030&#8243; media_width_percent=\u00bb100&#8243; uncode_shortcode_id=\u00bb864447&#8243; el_class=\u00bbnone-display\u00bb][vc_empty_space empty_h=\u00bb5&#8243;][vc_empty_space empty_h=\u00bb2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb100&#8243; back_color=\u00bbcolor-138503&#8243; back_image=\u00bb112266&#8243; back_attachment=\u00bbscroll\u00bb back_position=\u00bbcenter bottom\u00bb parallax=\u00bbyes\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider_inv=\u00bbtilt\u00bb shape_bottom_invert=\u00bbyes\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb100&#8243; shape_bottom_color=\u00bbcolor-681992&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb medium_visibility=\u00bbyes\u00bb row_name=\u00bbiphone\u00bb el_class=\u00bbgradient\u00bb uncode_shortcode_id=\u00bb204395&#8243; back_color_type=\u00bbuncode-palette\u00bb shape_bottom_color_type=\u00bbuncode-palette\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; style=\u00bbdark\u00bb overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb7&#8243; align_mobile=\u00bbalign_center_mobile\u00bb mobile_width=\u00bb0&#8243; css_animation=\u00bbbottom-t-top\u00bb animation_delay=\u00bb200&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb276875&#8243; column_width_pixel=\u00bb1000&#8243;][vc_empty_space empty_h=\u00bb1&#8243;][vc_single_image media=\u00bb138431&#8243; media_width_percent=\u00bb60&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb482822&#8243;][vc_button button_color=\u00bbcolor-681992&#8243; border_width=\u00bb0&#8243; uncode_shortcode_id=\u00bb194054&#8243; width=\u00bb216&#8243; link=\u00bburl:%23descripci%C3%B3ndelestudio|title:Preguntas%20frecuentes|\u00bb button_color_type=\u00bbuncode-palette\u00bb el_class=\u00bbnone-display\u00bb]M\u00e1s informaci\u00f3n[\/vc_button][vc_empty_space empty_h=\u00bb0&#8243;][vc_column_text text_color=\u00bbcolor-jevc\u00bb uncode_shortcode_id=\u00bb137548&#8243; text_color_type=\u00bbuncode-palette\u00bb]El IDRX-42 (GSK6042981) es un inhibidor altamente selectivo y potente de la prote\u00edna KIT, que es hiperactiva en muchas personas con GIST, lo que provoca el crecimiento y la acumulaci\u00f3n de las c\u00e9lulas cancerosas.[\/vc_column_text][vc_column_text text_color=\u00bbcolor-196438&#8243; uncode_shortcode_id=\u00bb164243&#8243; text_color_type=\u00bbuncode-palette\u00bb el_class=\u00bbnone-display\u00bb]Haga clic aqu\u00ed para ver un v\u00eddeo sobre StrateGIST 3, donde se explica el objetivo del estudio, qui\u00e9n puede participar, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_empty_space empty_h=\u00bb0&#8243;][vc_empty_space empty_h=\u00bb5&#8243;][vc_empty_space empty_h=\u00bb2&#8243;][vc_single_image media=\u00bb123030&#8243; media_width_percent=\u00bb100&#8243; uncode_shortcode_id=\u00bb167729&#8243; el_class=\u00bbnone-display\u00bb][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb50&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb2&#8243; top_padding=\u00bb4&#8243; bottom_padding=\u00bb3&#8243; back_color=\u00bbcolor-773321&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; bottom_divider=\u00bbtilt\u00bb uncode_shortcode_id=\u00bb131569&#8243; back_color_type=\u00bbuncode-palette\u00bb row_name=\u00bbstudy-description\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; column_width_pixel=\u00bb1000&#8243; uncode_shortcode_id=\u00bb145453&#8243;][vc_custom_heading text_color=\u00bbcolor-138503&#8243; heading_semantic=\u00bbh1&#8243; desktop_visibility=\u00bbyes\u00bb medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb uncode_shortcode_id=\u00bb671518&#8243; text_color_type=\u00bbuncode-palette\u00bb]<strong>\u00bfQu\u00e9 es StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=\u00bbcolor-xsdn\u00bb uncode_shortcode_id=\u00bb775611&#8243; text_color_type=\u00bbuncode-palette\u00bb]<span style=\"font-weight: 400;\"><strong style=\"font-size: 20px; color: #ffffff;\">StrateGIST 3<\/strong> es un ensayo cl\u00ednico que prueba un medicamento experimental (medicamento del estudio) llamado IDRX-42 (GSK6042981) en adultos con tumores del estroma gastrointestinal (GIST, por sus siglas en ingl\u00e9s) metast\u00e1sicos y\/o no resecables que han progresado o que no toleraron el tratamiento de primera l\u00ednea con imatinib.<\/span> <span style=\"font-weight: 400;\">Los investigadores quieren saber m\u00e1s sobre la seguridad del IDRX-42 (GSK6042981) y comparar sus efectos con el sunitinib, que es un tratamiento aprobado en algunos pa\u00edses para el tipo de GIST que se est\u00e1 estudiando.<\/span> <span style=\"font-weight: 400;\">Este ensayo se basar\u00e1 en lo aprendido sobre IDRX-42 (GSK6042981) en un&nbsp;ensayo anterior en personas con GIST.<\/span>[\/vc_column_text][vc_column_text text_color=\u00bbcolor-xsdn\u00bb uncode_shortcode_id=\u00bb994197&#8243; text_color_type=\u00bbuncode-palette\u00bb el_class=\u00bbnone-display\u00bb]El v\u00eddeo a continuaci\u00f3n ofrece una visi\u00f3n general de StrateGIST 3, que incluyen el objetivo del estudio, qui\u00e9n puede participar en \u00e9l, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_empty_space empty_h=\u00bb3&#8243;][vc_button button_color=\u00bbcolor-196438&#8243; border_animation=\u00bbbtn-ripple-out\u00bb border_width=\u00bb0&#8243; display=\u00bbinline\u00bb link=\u00bburl:%23lugar|title:Participe%20en%20el%20estudio|\u00bb button_color_type=\u00bbuncode-palette\u00bb width=\u00bb216&#8243; uncode_shortcode_id=\u00bb132884&#8243;]Encuentre un centro del ensayo cl\u00ednico[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb2&#8243; top_padding=\u00bb7&#8243; bottom_padding=\u00bb7&#8243; back_color=\u00bbcolor-138503&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_top_divider=\u00bbdefault\u00bb top_divider=\u00bbtilt\u00bb shape_top_h_use_pixel=\u00bb\u00bb shape_top_height=\u00bb100&#8243; shape_top_color=\u00bbcolor-681992&#8243; shape_top_opacity=\u00bb100&#8243; shape_top_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider=\u00bbtilt\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb150&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb uncode_shortcode_id=\u00bb152579&#8243; back_color_type=\u00bbuncode-palette\u00bb shape_top_color_type=\u00bbuncode-palette\u00bb][vc_column column_width_percent=\u00bb100&#8243; gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; sticky=\u00bbyes\u00bb width=\u00bb1\/2&#8243; uncode_shortcode_id=\u00bb179542&#8243;][vc_row_inner limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; position_horizontal=\u00bbright\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb242247&#8243;][vc_custom_heading text_size=\u00bb\u00bb uncode_shortcode_id=\u00bb506177&#8243;]<strong>\u00bfQu\u00e9 ocurre durante el ensayo?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=\u00bb183718&#8243;]<span style=\"font-weight: 400;\">El ensayo probar\u00e1 el medicamento del estudio, IDRX-42, en adultos con GIST metast\u00e1sico y\/o no resecable que ha progresado mientras tomaban imatinib o que no toleran los efectos secundarios del imatinib. El objetivo es comparar los efectos del IDRX-42 versus el sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 es un medicamento en investigaci\u00f3n y no ha sido aprobado por ninguna autoridad sanitaria para su uso fuera de un ensayo cl\u00ednico.<\/span>[\/vc_column_text][vc_empty_space empty_h=\u00bb4&#8243;][\/vc_column][vc_column column_width_percent=\u00bb95&#8243; gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; css_animation=\u00bbalpha-anim\u00bb width=\u00bb1\/2&#8243; uncode_shortcode_id=\u00bb900895&#8243;][vc_custom_heading text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb954054&#8243;]Consentimiento informado[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb195636&#8243;]<span style=\"font-weight: 400;\">Antes de que decida si desea participar, el equipo del estudio revisar\u00e1 los detalles del ensayo con usted. Esto incluye los posibles riesgos y beneficios, as\u00ed como lo que puede esperar si participa. Si decide participar, le pedir\u00e1n que firme un documento de consentimiento informado. Esto confirma que comprende el ensayo y que est\u00e1 dispuesto a participar para determinar si re\u00fane los requisitos.<\/span>[\/vc_column_text][vc_separator sep_color=\u00bbcolor-prif\u00bb uncode_shortcode_id=\u00bb169390&#8243; sep_color_type=\u00bbuncode-palette\u00bb][vc_custom_heading text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb178847&#8243;]Selecci\u00f3n[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb350149&#8243;]<span style=\"font-weight: 400;\">Para ver si re\u00fane los requisitos, tendr\u00e1 al menos 1 visita al centro del estudio para responder preguntas sobre su salud y los medicamentos que toma, y para someterse a algunas pruebas.<\/span>[\/vc_column_text][vc_separator sep_color=\u00bbcolor-prif\u00bb uncode_shortcode_id=\u00bb169390&#8243; sep_color_type=\u00bbuncode-palette\u00bb][vc_custom_heading text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb209503&#8243;]Tratamiento del estudio[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb132873&#8243;]<span style=\"font-weight: 400;\">Si re\u00fane los requisitos para el ensayo, se le asignar\u00e1 al azar a un grupo para recibir IDRX-42 o sunitinib (el tratamiento aprobado).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 se suministra en forma de comprimidos que se toman por v\u00eda oral una vez al d\u00eda en casa. El IDRX-42 se toma todos los d\u00edas. El sunitinib se toma durante 28 d\u00edas seguidos y, a continuaci\u00f3n, se realiza una pausa de 14 d\u00edas (salvo que su m\u00e9dico le indique otra cosa)\u00a0<\/span>.<\/p>\n<p><span style=\"font-weight: 400;\">Durante el periodo de tratamiento del estudio, acudir\u00e1 al centro del estudio para comprobar su estado de salud y c\u00f3mo responde su c\u00e1ncer al tratamiento del estudio (IDRX-42 o sunitinib).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Si est\u00e1 tomando sunitinib y su c\u00e1ncer empeora, es posible que pueda cambiar a IDRX-42.<\/span><\/p>\n<p><strong>El promotor del ensayo cl\u00ednico pagar\u00e1 el tratamiento del estudio (IDRX-42 o sunitinib), las visitas y las pruebas relacionadas con el estudio. Se reembolsar\u00e1n los gastos de viaje relacionados con las visitas del estudio.<\/strong>[\/vc_column_text][vc_separator sep_color=\u00bbcolor-prif\u00bb uncode_shortcode_id=\u00bb447472&#8243; sep_color_type=\u00bbuncode-palette\u00bb][vc_custom_heading text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb165143&#8243;]Seguimiento[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb435261&#8243;]<span style=\"font-weight: 400;\">Una vez que usted y su m\u00e9dico decidan interrumpir el tratamiento del estudio, tendr\u00e1 2 visitas m\u00e1s y mantendr\u00e1 llamadas telef\u00f3nicas con el equipo del estudio cada 3 meses.<\/span>[\/vc_column_text][vc_empty_space empty_h=\u00bb2&#8243;][vc_button button_color=\u00bbcolor-681992&#8243; border_animation=\u00bbbtn-ripple-out\u00bb border_width=\u00bb0&#8243; uncode_shortcode_id=\u00bb626023&#8243; link=\u00bburl:https%3A%2F%2Fstg.strategist1trial.com%2Ffaqs-2|title:Preguntas%20frecuentes|\u00bb button_color_type=\u00bbuncode-palette\u00bb]Explore las preguntas frecuentes sobre StrateGIST\u00a03[\/vc_button][vc_empty_space empty_h=\u00bb2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_top_divider=\u00bbdefault\u00bb top_divider=\u00bbtilt\u00bb shape_top_h_use_pixel=\u00bb\u00bb shape_top_height=\u00bb100&#8243; shape_top_color=\u00bbcolor-773321&#8243; shape_top_opacity=\u00bb100&#8243; shape_top_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider=\u00bbtilt\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb150&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; uncode_shortcode_id=\u00bb992596&#8243; back_color_type=\u00bbuncode-solid\u00bb shape_top_color_type=\u00bbuncode-palette\u00bb back_color_solid=\u00bb#f2f6ff\u00bb][vc_column column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; sticky=\u00bbyes\u00bb width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb580905&#8243;][vc_row_inner limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; position_horizontal=\u00bbright\u00bb position_vertical=\u00bbmiddle\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb111259&#8243;][vc_empty_space empty_h=\u00bb3&#8243;][vc_custom_heading text_size=\u00bb\u00bb uncode_shortcode_id=\u00bb506177&#8243;]<strong>\u00bfQu\u00e9 ocurre durante el ensayo?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb105390&#8243;]<span style=\"font-weight: 400;\">El ensayo probar\u00e1 el medicamento del estudio, IDRX-42 (GSK6042981), en adultos con GIST metast\u00e1sico y\/o no resecable que ha progresado mientras tomaban imatinib o que no toleran los efectos secundarios del imatinib. El objetivo es comparar la seguridad y los efectos del IDRX-42 (GSK6042981) con los del sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 (GSK6042981) es un medicamento en investigaci\u00f3n y no ha sido aprobado por ninguna autoridad sanitaria para su uso fuera de un ensayo cl\u00ednico.<\/span>[\/vc_column_text][vc_single_image media=\u00bb122810&#8243; media_width_percent=\u00bb100&#8243; uncode_shortcode_id=\u00bb142280&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb158094&#8243;][vc_custom_heading uncode_shortcode_id=\u00bb175823&#8243;]Su recorrido en StrateGIST\u00a03[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb limit_content=\u00bb\u00bb uncode_shortcode_id=\u00bb663441&#8243;][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb158744&#8243;][vc_single_image media=\u00bb142602&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb105349&#8243;][vc_single_image media=\u00bb142625&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb645491&#8243;][vc_single_image media=\u00bb142648&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb131765&#8243;][vc_single_image media=\u00bb142671&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb148117&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb limit_content=\u00bb\u00bb uncode_shortcode_id=\u00bb143909&#8243;][vc_column_inner width=\u00bb1\/1&#8243;][vc_single_image media=\u00bb138551&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb165287&#8243;][vc_single_image media=\u00bb138491&#8243; media_width_percent=\u00bb11&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb197707&#8243;][vc_single_image media=\u00bb138531&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb840834&#8243;][vc_single_image media=\u00bb138491&#8243; media_width_percent=\u00bb11&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb746250&#8243;][vc_single_image media=\u00bb140915&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb153235&#8243;][vc_single_image media=\u00bb138491&#8243; media_width_percent=\u00bb11&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb121070&#8243;][vc_single_image media=\u00bb138511&#8243; media_width_percent=\u00bb85&#8243; alignment=\u00bbcenter\u00bb uncode_shortcode_id=\u00bb868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=\u00bb3&#8243;][vc_row_inner limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb888870&#8243;][vc_button button_color=\u00bbcolor-773321&#8243; border_width=\u00bb0&#8243; link=\u00bburl:https%3A%2F%2Fes-es.stg.strategist3trial.com%2Fpreguntas-frecuentes%2F|title:Preguntas%20frecuentes|\u00bb uncode_shortcode_id=\u00bb203766&#8243; button_color_type=\u00bbuncode-palette\u00bb]Preguntas frecuentes[\/vc_button][vc_empty_space empty_h=\u00bb3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb2&#8243; top_padding=\u00bb3&#8243; bottom_padding=\u00bb3&#8243; back_color=\u00bbcolor-xsdn\u00bb back_image=\u00bb111788&#8243; parallax=\u00bbyes\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_top_divider=\u00bbdefault\u00bb top_divider=\u00bbtilt\u00bb shape_top_h_use_pixel=\u00bb\u00bb shape_top_height=\u00bb100&#8243; shape_top_opacity=\u00bb100&#8243; shape_top_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider=\u00bbtilt\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb100&#8243; shape_bottom_opacity=\u00bb100&#8243; shape_bottom_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb uncode_shortcode_id=\u00bb155709&#8243; back_color_type=\u00bbuncode-palette\u00bb row_name=\u00bblocations\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb881793&#8243; column_width_pixel=\u00bb900&#8243;][vc_empty_space][vc_custom_heading text_size=\u00bb\u00bb uncode_shortcode_id=\u00bb176181&#8243;]<span style=\"font-weight: 400;\">\u00bfLe interesa obtener m\u00e1s informaci\u00f3n? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb183639&#8243;]<span style=\"font-weight: 400;\">Hable con su m\u00e9dico para obtener m\u00e1s informaci\u00f3n y haga clic en el enlace a continuaci\u00f3n para encontrar un centro del ensayo StrateGIST 1 cercano.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=\u00bb654154&#8243;]<b>La participaci\u00f3n en el ensayo es voluntaria y puede decidir retirarse en cualquier momento.<\/b>[\/vc_column_text][vc_empty_space empty_h=\u00bb2&#8243;][vc_button button_color=\u00bbcolor-773321&#8243; border_animation=\u00bbbtn-ripple-out\u00bb border_width=\u00bb0&#8243; uncode_shortcode_id=\u00bb214268&#8243; link=\u00bburl:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:Preguntas%20frecuentes|\u00bb button_color_type=\u00bbuncode-palette\u00bb]Encuentre un centro del ensayo cl\u00ednico[\/vc_button][vc_empty_space empty_h=\u00bb5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb2&#8243; top_padding=\u00bb3&#8243; bottom_padding=\u00bb3&#8243; back_color=\u00bbcolor-xsdn\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; uncode_shortcode_id=\u00bb936538&#8243; back_color_type=\u00bbuncode-palette\u00bb row_name=\u00bblocation\u00bb][vc_column column_width_use_pixel=\u00bbyes\u00bb align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/1&#8243; uncode_shortcode_id=\u00bb881793&#8243; column_width_pixel=\u00bb900&#8243;][vc_custom_heading text_size=\u00bb\u00bb uncode_shortcode_id=\u00bb118699&#8243;]\u00bfLe interesa obtener m\u00e1s informaci\u00f3n?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=\u00bb562784&#8243;]<span style=\"font-weight: 400;\">Consulte con su m\u00e9dico para obtener m\u00e1s informaci\u00f3n sobre StrateGIST\u00a03.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tambi\u00e9n puede hacer clic en una ubicaci\u00f3n del mapa de abajo para encontrar un centro StrateGIST 3 cerca de usted. StrateGIST 3 estar\u00e1 disponible en hasta 160 centros de ensayos cl\u00ednicos de todo el mundo. Es posible que se abran nuevos centros, por lo que le recomendamos que consulte las actualizaciones.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Se reembolsar\u00e1n los gastos de viaje relacionados con las visitas del estudio.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; override_padding=\u00bbyes\u00bb h_padding=\u00bb2&#8243; top_padding=\u00bb2&#8243; bottom_padding=\u00bb5&#8243; back_color=\u00bbcolor-xsdn\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; uncode_shortcode_id=\u00bb150898&#8243; back_color_type=\u00bbuncode-palette\u00bb][vc_column width=\u00bb1\/1&#8243;][vc_column_text uncode_shortcode_id=\u00bb326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"es\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; desktop_visibility=\u00bbyes\u00bb medium_visibility=\u00bbyes\u00bb mobile_visibility=\u00bbyes\u00bb uncode_shortcode_id=\u00bb107948&#8243;][vc_column width=\u00bb1\/1&#8243;][vc_row_inner limit_content=\u00bb\u00bb][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243; uncode_shortcode_id=\u00bb136670&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb961362&#8243; subheading=\u00bb(obtenga informaci\u00f3n sobre el ensayo y acepte participar)\u00bb]Consentimiento informado[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243; uncode_shortcode_id=\u00bb443498&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL2hlYWx0aC1zdGF0dXMucG5nIi8+IiBjb250ZW50ID0gIjxoMz5TZWxlY2Npw7NuPC9oMz48ZGl2PjxoNj5QYXJhIHZlciBzaSByZcO6bmUgbG9zIHJlcXVpc2l0b3MsIHRlbmRyw6EgYWwgbWVub3MgMSB2aXNpdGEgYWwgY2VudHJvIGRlbCBlc3R1ZGlvIHBhcmEgcmVzcG9uZGVyIHByZWd1bnRhcyBzb2JyZSBzdSBzYWx1ZCB5IGxvcyBtZWRpY2FtZW50b3MgcXVlIHRvbWEsIHkgcGFyYSBzb21ldGVyc2UgYSBhbGd1bmFzIHBydWViYXMuPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb927570&#8243; subheading=\u00bb(ver si re\u00fane los requisitos)\u00bb]Selecci\u00f3n[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243; uncode_shortcode_id=\u00bb755785&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb665102&#8243; subheading=\u00bbIDRX-42 o sunitinib\u00bb]Tratamiento del estudio[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=\u00bb100&#8243; align_horizontal=\u00bbalign_center\u00bb gutter_size=\u00bb3&#8243; overlay_alpha=\u00bb50&#8243; shift_x=\u00bb0&#8243; shift_y=\u00bb0&#8243; shift_y_down=\u00bb0&#8243; z_index=\u00bb0&#8243; medium_width=\u00bb0&#8243; mobile_width=\u00bb0&#8243; width=\u00bb1\/4&#8243; uncode_shortcode_id=\u00bb127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPlNlZ3VpbWllbnRvPC9oMj48ZGl2PjxoNj5VbmEgdmV6IHF1ZSB1c3RlZCB5IHN1IG3DqWRpY28gZGVjaWRhbiBpbnRlcnJ1bXBpciBlbCB0cmF0YW1pZW50byBkZWwgZXN0dWRpbywgdGVuZHLDoSAyIHZpc2l0YXMgbcOhcyB5IHJlYWxpemFyw6EgbGxhbWFkYXMgdGVsZWbDs25pY2FzIGNvbiBlbCBlcXVpcG8gZGVsIGVzdHVkaW8gY2FkYSAzIG1lc2VzLjwvaDY+PGJyPjxicj48L2Rpdj4iXQ==[\/vc_raw_html][vc_custom_heading heading_semantic=\u00bbh3&#8243; text_size=\u00bbh3&#8243; uncode_shortcode_id=\u00bb152286&#8243;]Seguimiento[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=\u00bb100&#8243; back_color=\u00bbcolor-138503&#8243; back_image=\u00bb141532&#8243; back_repeat=\u00bbno-repeat\u00bb back_attachment=\u00bbscroll\u00bb back_position=\u00bbcenter center\u00bb parallax=\u00bbyes\u00bb overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb4&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; enable_bottom_divider=\u00bbdefault\u00bb bottom_divider_inv=\u00bbtilt\u00bb shape_bottom_invert=\u00bbyes\u00bb shape_bottom_flip=\u00bbyes\u00bb shape_bottom_h_use_pixel=\u00bb\u00bb shape_bottom_height=\u00bb100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-138781","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.\" \/>\n\t<meta name=\"robots\" content=\"noindex, nofollow, max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/stg.strategist3trial.com\/es\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Caidya IDRC3 Study -\" \/>\n\t\t<meta property=\"og:type\" content=\"website\" \/>\n\t\t<meta property=\"og:title\" content=\"StrateGIST3 es un estudio para adultos con GIST avanzado.\" \/>\n\t\t<meta property=\"og:description\" content=\"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/stg.strategist3trial.com\/es\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"StrateGIST3 es un estudio para adultos con GIST avanzado.\" \/>\n\t\t<meta name=\"twitter:description\" content=\"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#listItem\",\"name\":\"Ensayo StrateGIST3\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#listItem\",\"position\":2,\"name\":\"Ensayo StrateGIST3\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#organization\",\"name\":\"The StrateGIST1 Trial\",\"url\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#webpage\",\"url\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/\",\"name\":\"StrateGIST3 es un estudio para adultos con GIST avanzado.\",\"description\":\"StrateGIST3 es un estudio de investigaci\\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#breadcrumblist\"},\"datePublished\":\"2018-04-09T10:14:38+00:00\",\"dateModified\":\"2026-04-24T18:47:24+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/\",\"name\":\"The StrateGIST1 Trial\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/stg.strategist3trial.com\\\/es\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"StrateGIST3 es un estudio para adultos con GIST avanzado.","description":"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.","canonical_url":"https:\/\/stg.strategist3trial.com\/es\/","robots":"noindex, nofollow, max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/stg.strategist3trial.com\/es\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/stg.strategist3trial.com\/es\/#listItem","position":1,"name":"Home","item":"https:\/\/stg.strategist3trial.com\/es\/","nextItem":{"@type":"ListItem","@id":"https:\/\/stg.strategist3trial.com\/es\/#listItem","name":"Ensayo StrateGIST3"}},{"@type":"ListItem","@id":"https:\/\/stg.strategist3trial.com\/es\/#listItem","position":2,"name":"Ensayo StrateGIST3","previousItem":{"@type":"ListItem","@id":"https:\/\/stg.strategist3trial.com\/es\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/stg.strategist3trial.com\/es\/#organization","name":"The StrateGIST1 Trial","url":"https:\/\/stg.strategist3trial.com\/es\/"},{"@type":"WebPage","@id":"https:\/\/stg.strategist3trial.com\/es\/#webpage","url":"https:\/\/stg.strategist3trial.com\/es\/","name":"StrateGIST3 es un estudio para adultos con GIST avanzado.","description":"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/stg.strategist3trial.com\/es\/#website"},"breadcrumb":{"@id":"https:\/\/stg.strategist3trial.com\/es\/#breadcrumblist"},"datePublished":"2018-04-09T10:14:38+00:00","dateModified":"2026-04-24T18:47:24+00:00"},{"@type":"WebSite","@id":"https:\/\/stg.strategist3trial.com\/es\/#website","url":"https:\/\/stg.strategist3trial.com\/es\/","name":"The StrateGIST1 Trial","inLanguage":"es-ES","publisher":{"@id":"https:\/\/stg.strategist3trial.com\/es\/#organization"}}]},"og:locale":"es_ES","og:site_name":"Caidya IDRC3 Study -","og:type":"website","og:title":"StrateGIST3 es un estudio para adultos con GIST avanzado.","og:description":"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.","og:url":"https:\/\/stg.strategist3trial.com\/es\/","twitter:card":"summary_large_image","twitter:title":"StrateGIST3 es un estudio para adultos con GIST avanzado.","twitter:description":"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar."},"aioseo_meta_data":{"post_id":"138781","title":"StrateGIST3 es un estudio para adultos con GIST avanzado.","description":"StrateGIST3 es un estudio de investigaci\u00f3n para adultos con GIST avanzado que ha progresado mientras tomaban imatinib o que no lo pueden tolerar.","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"website","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2025-09-11 10:05:09","updated":"2026-04-24 21:35:24","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/stg.strategist3trial.com\/es\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tEnsayo StrateGIST3\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/stg.strategist3trial.com\/es\/"},{"label":"Ensayo StrateGIST3","link":"https:\/\/stg.strategist3trial.com\/es\/"}],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/pages\/138781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/comments?post=138781"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/pages\/138781\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/es\/wp-json\/wp\/v2\/media?parent=138781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}